entity,start_date,end_date,context,AARSRAPPORT_html,AARSRAPPORT_pdf,AARSRAPPORT_xml,AddressOfAuditorCountry,AddressOfAuditorDistrictName,AddressOfAuditorPostCodeIdentifier,AddressOfAuditorStreetBuildingIdentifier,AddressOfAuditorStreetName,AddressOfReportingEntityDistrictName,AddressOfReportingEntityPostCodeIdentifier,AddressOfReportingEntityStreetBuildingIdentifier,AddressOfReportingEntityStreetName,AddressOfSubmittingEnterprisePostcodeAndTown,AddressOfSubmittingEnterpriseStreetAndNumber,AddresseeOfAuditorsReportOnAuditedFinancialStatements,ClassOfReportingEntity,ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement,ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults,DateOfApprovalOfAnnualReport,DateOfFoundationOfReportingEntity,DateOfGeneralMeeting,DescriptionOfAuditor,DescriptionOfClassOfIssuedShares,DescriptionOfMethodsOfCurrentTaxReceivablesAndLiabilities,DescriptionOfMethodsOfDividends,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables,DescriptionOfQualificationsOfAuditedFinancialStatements,HomepageOfReportingEntity,IdentificationNumberCvrOfAuditFirm,IdentificationNumberCvrOfReportingEntity,IdentificationNumberCvrOfSubmittingEnterprise,IdentificationNumberOfAuditor,IdentificationOfApprovedAnnualReport,IdentificationOfAuditedFinancialStatements,InformationOnTypeOfSubmittedReport,ManagementsStatementAboutManagementsReview,NameAndSurnameOfAuditor,NameAndSurnameOfChairmanOfGeneralMeeting,NameAndSurnameOfMemberOfExecutiveBoard,NameOfReportingEntity,NameOfSubmittingEnterprise,OpinionOnAuditedFinancialStatements,PlaceOfSignatureOfStatement,PrecedingReportingPeriodStartDate,PredingReportingPeriodEndDate,ProfitLoss,RecommendationForApprovalOfAnnualReportByGeneralMeeting,RegisteredOfficeOfReportingEntity,ReportingPeriodEndDate,ReportingPeriodStartDate,RetrospectiveInformationOnContributedCapital,SelectedElementsFromReportingClassC,TelephoneNumberOfReportingEntity,TypeOfAuditorAssistance,_id,_index,_score,cvrNummer,indlaesningsId,indlaesningsTidspunkt,offentliggoerelsesTidspunkt,offentliggoerelsestype,omgoerelse,regNummer,regnskabsperiode_slutDato,regnskabsperiode_startDato,sagsNummer,sidstOpdateret,AdjustmentsForCurrentTaxOfPriorPeriod,AdjustmentsForCurrentTaxRelatingToTaxRateChangesOrImpositionOfNewTaxes,AdjustmentsForDeferredTax,AverageNumberOfEmployees,CurrentTaxExpense,DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss,EmployeeBenefitsExpense,ExchangeRateAdjustmentsOtherFinanceExpenses,ExchangeRateAdjustmentsOtherFinanceIncome,GrossProfitLoss,InterestExpenseAssignedToGroupEnterprises,OtherFinanceExpenses,OtherFinanceIncome,OtherInterestIncome,PostemploymentBenefitExpense,ProfitLossFromOrdinaryActivitiesBeforeTax,ProfitLossFromOrdinaryOperatingActivities,TaxExpense,TaxExpenseOnOrdinaryActivities,WagesAndSalaries,Assets,ContributedCapital,CurrentAssets,CurrentDeferredTaxAssets,DeferredIncomeAssets,Equity,Goodwill,IntangibleAssets,Inventories,LiabilitiesAndEquity,LiabilitiesOtherThanProvisions,LongtermLiabilitiesOtherThanProvisions,ManufacturedGoodsAndGoodsForResale,NoncurrentAssets,OtherLongtermPayables,OtherShorttermPayables,PaidContributedCapital,Provisions,ProvisionsForDeferredTax,RetainedEarnings,ShorttermLiabilitiesOtherThanProvisions,ShorttermPayablesToGroupEnterprises,ShorttermPrepaymentsReceivedFromCustomers,ShorttermReceivables,ShorttermReceivablesFromGroupEnterprises,ShorttermTaxPayables,ShorttermTradePayables,ShorttermTradeReceivables,SignatureOfAuditorsDate,SignatureOfAuditorsPlace,NameOfAuditFirm,NameAndSurnameOfMemberOfSupervisoryBoard
73131510,2016-01-01,2016-12-31,c106,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,7936000.0,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2016-01-01,2016-12-31,c92,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,7936000.0,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,15000.0,0.0,-96000.0,9.0,1656000.0,1564000.0,7670000.0,46000.0,11000.0,18994000.0,217000.0,263000.0,14000.0,3000.0,787000.0,9511000.0,9760000.0,1575000.0,1575000.0,6883000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2016-12-31,2016-12-31,c109,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,40901000.0,2000000.0,28391000.0,274000.0,90000.0,27707000.0,12510000.0,12510000.0,2148000.0,40901000.0,13194000.0,96000.0,2148000.0,12510000.0,96000.0,7108000.0,2000000.0,0.0,0.0,25707000.0,13098000.0,5053000.0,458000.0,26243000.0,0.0,302000.0,177000.0,25879000.0,,,,
73131510,2016-12-31,2016-12-31,c233,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96000.0,,,,,,,,,,,,,,,,,,,,
73131510,2017-01-01,2017-01-01,c0,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,2000000.0,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-01-01,2017-01-01,c20,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,25707000.0,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-01-01,2017-12-31,c105,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,10743000.0,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-01-01,2017-12-31,c21,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,10743000.0,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-01-01,2017-12-31,c65,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,10743000.0,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,0.0,548000.0,146000.0,9.0,3061000.0,1563000.0,8811000.0,1000.0,4000.0,25589000.0,720000.0,721000.0,4000.0,0.0,874000.0,14498000.0,15215000.0,3755000.0,3755000.0,7937000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2018-06-11,Copenhagen,,
73131510,2017-01-01,2017-12-31,c67,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,KPMG Statsautoriseret Revisionspartnerselskab,
73131510,2017-01-01,2017-12-31,c68,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Tiina Marjatta Puhakka
73131510,2017-01-01,2017-12-31,c69,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Hans Christopher Elers Koch
73131510,2017-01-01,2017-12-31,c70,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Jeanette Sandholmen
73131510,2017-01-01,2017-12-31,c83,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-12-31,2017-12-31,c110,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,67147000.0,2000000.0,56200000.0,0.0,421000.0,38450000.0,10947000.0,10947000.0,4054000.0,67147000.0,28277000.0,26000.0,4054000.0,10947000.0,26000.0,8277000.0,2000000.0,420000.0,420000.0,36450000.0,28251000.0,17844000.0,545000.0,52146000.0,3590000.0,1397000.0,188000.0,48135000.0,,,,
73131510,2017-12-31,2017-12-31,c119,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-12-31,2017-12-31,c2,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,2000000.0,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-12-31,2017-12-31,c22,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,36450000.0,,,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2017-12-31,2017-12-31,c58,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzc3LzMzLzRhLzVlLzc4ZTEtNDNjNi1hMGQzLTJjMzM0M2MyZTBkNA.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzNkLzYyLzkwLzg0LzliNDEtNGJkNy04YWY1LWYxZTJiYzViNGQ3NA.xml,Danmark,KÃ¸benhavn Ã,2100.0,28.0,DampfÃ¦rgevej,SÃ¸borg,2860.0,"62 A, 5. a.",VandtÃ¥rnsvej,2900 Hellerup,Strandvejen 44,To the Shareholder of Merck Life Science A/S,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish F'inancial Statements Act.,"lt is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2o17 and of the result of the Company's operations for the year  1 January -31 December 2017.",2018-06-11,1982-12-31,2018-06-12,State Authorised Public Accountant,"The share capital consists of 2 shares of a nominal value of TDKK 1,000. No shares carry any special rights.",Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.,Proposed dividends are recognised as a liability at the date on which they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Cost of sales comprises costs of goods sold associated to the invoiced revenue.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.","Financial income and financial expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.","With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.",Financial liabilities are measured at amortised cost.,Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,"We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.",www.merckgroup.com,25578198.0,73131510.0,33771231.0,mne30154,The Board of Directors and the Executive Board have today discussed and approved the annual report of Merck Life Science A/S for the financial year 1 Januar -31 December 2017.,"We have audited the Financial Statements of Merck Life Science A/S for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The Financial Statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Kenn Wolff Hansen,Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,"In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.",SÃ¸borg,2016-01-01,2016-12-31,,We recommend that the annual report will be approved at the annual general meeting.,Gladsaxe,2017-12-31,2017-01-01,There have been no changes in the share capital during the last 5 years.,1.0,70 10 56 45,RevisionspÃ¥tegning,urn:ofk:oid:25846945,indberetninger-20180424,2.5124277999999998,73131510.0,AWQRbb7B0wkEsASkt1SF,2018-06-18T05:46:19.925Z,2018-06-18T05:45:57.654Z,regnskab,0.0,,2017-12-31,2017-01-01,X18-AR-31-VC,2018-06-18T05:45:58.132Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26000.0,,,,,,,,,,,,,,,,,,,,
